Literature DB >> 2591644

Chronic low frequency electrical activation for one week corrects nerve conduction velocity deficits in rats with diabetes of three months duration.

N E Cameron1, M A Cotter, S Robertson.   

Abstract

This study examined the effect of chronic electrical activation on conduction velocity deficits after three months of streptozotocin-induced diabetes. There were 30% and 20% reductions in conduction velocity in diabetic animals for tibialis anterior and saphenous nerves, respectively (p less than 0.01). Unilateral electrical stimulation of the common peroneal nerve, which contains axons supplying tibialis anterior but not saphenous nerve, was carried out in a group of diabetic and a group of normal control rats. Stimulation was given over seven days, at 10 Hz for 8 h/day. Final experiments were carried out at least 17 h after the last stimulation session. In normal rats stimulation had no effect on conduction velocity in either nerve. In diabetic animals, however, tibialis anterior conduction was within the normal control range for the stimulated nerve. In contrast, the contralateral unstimulated nerve had reduced conduction velocity (p less than 0.001), which was within the unoperated diabetic control range. There were no effects on saphenous nerve conduction, comparing stimulated and unstimulated legs. We conclude that chronic increases in nerve electrical activation promote mechanisms that reverse conduction deficits in diabetic rats.

Entities:  

Mesh:

Year:  1989        PMID: 2591644     DOI: 10.1007/bf00274538

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  5 in total

1.  Regional blood flow in resting and stimulated sciatic nerve of diabetic rats.

Authors:  W W Monafo; S G Eliasson; S Shimazaki; H Sugimoto
Journal:  Exp Neurol       Date:  1988-03       Impact factor: 5.330

Review 2.  Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy.

Authors:  D A Greene; S Lattimer; J Ulbrecht; P Carroll
Journal:  Diabetes Care       Date:  1985 May-Jun       Impact factor: 19.112

3.  In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.

Authors:  S A Lattimer; A A Sima; D A Greene
Journal:  Am J Physiol       Date:  1989-02

4.  Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.

Authors:  D A Greene; P V De Jesus; A I Winegrad
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

5.  Effect of diabetes on motor conduction velocity in different branches of the rat sciatic nerve.

Authors:  N E Cameron; M A Cotter; J Harrison
Journal:  Exp Neurol       Date:  1986-06       Impact factor: 5.330

  5 in total
  10 in total

1.  Changes in purinergic responses of the rabbit isolated central ear artery after chronic electrical stimulation in vivo.

Authors:  K I Maynard; A Loesch; G Burnstock
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 2.  Interferential current therapy.

Authors:  G C Goats
Journal:  Br J Sports Med       Date:  1990-06       Impact factor: 13.800

Review 3.  The Electrical Response to Injury: Molecular Mechanisms and Wound Healing.

Authors:  Brian Reid; Min Zhao
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-02-01       Impact factor: 4.730

4.  The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.

Authors:  N E Cameron; M A Cotter; K C Dines; S Robertson; D Cox
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.

Authors:  N E Cameron; M A Cotter; S Robertson
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?

Authors:  M J Young; A Veves; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

7.  Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; S Robertson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

8.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

9.  Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.

Authors:  K S Suh; S J Oh; J T Woo; S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi; I K Park
Journal:  Korean J Intern Med       Date:  1999-07       Impact factor: 2.884

10.  High-frequency electrical stimulation can be a complementary therapy to promote nerve regeneration in diabetic rats.

Authors:  Chia-Hong Kao; Jia-Jin J Chen; Yuan-Man Hsu; Da-Tian Bau; Chun-Hsu Yao; Yueh-Sheng Chen
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.